The Times

.

Immuno Cure BioTech acquires Shanghai Teresa Healthcare

  • Written by Auzzi Shopping

Integrating Electroporation Technology & DNA Vaccine Platforms

HONG KONG SAR - Media OutReach - 20 September 2022 - Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced today the acquisition of 92.6% of Shanghai Teresa Healthcare, the pioneer of electroporation technology and device in China.


Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 18

Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 2 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 3 in /httpdocs/templates/gk_university/html/pagination.php on line 34
hacklink hack forum hacklink film izle hacklink makrobetperabetgamdomonline casinos australiaonwinonline casino australiasahabetyasadışı ilaç satışılove marketim1Red casinojojobetdeneme bonusu veren sitelerslot sitelerideneme bonusu veren sitelerเว็บสล็อตเว็บสล็อตmix parlaydeneme bonusu veren siteleraustralian online casinosonline pokiesroyal reels 17royalreels.pokerroyal reels casinothe pokies casinojojobetjojobetjojobetbahislionnakitbahisikimisliholiganbetjojobetcasibomcasibom